InvestorsHub Logo
Followers 29
Posts 2139
Boards Moderated 0
Alias Born 05/03/2020

Re: Cody4 post# 152381

Thursday, 03/11/2021 9:57:32 AM

Thursday, March 11, 2021 9:57:32 AM

Post# of 233014
Cody4 - "In our CD10 COVID mild-to-moderate trial with leronlimab, we noted a reduction in adverse events or symptoms including fatigue, diarrhea, chest pain, fatigue, muscle weakness, and anxiety in treated vs. placebo groups."

IMHO - for our LH trial (no pump): Point. Set. Match.

GLTU/A.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News